Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 22768723)

1.

Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study.

Braido F, Riccio AM, Rogkakou A, Massacane P, Guerra L, Fumagalli F, Stagi E, Balestracci S, Porcu A, Canonica GW.

Eur Ann Allergy Clin Immunol. 2012 Apr;44(2):48-53.

PMID:
22768723
2.

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.

Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF.

Ann Allergy Asthma Immunol. 2005 Dec;95(6):551-7.

PMID:
16400895
3.

Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.

Razi C, Bakirtas A, Harmanci K, Turktas I, Erbas D.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):767-74.

PMID:
17201236
4.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
5.

Efficacy of montelukast for treating perennial allergic rhinitis.

Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF.

Allergy Asthma Proc. 2007 May-Jun;28(3):296-304.

PMID:
17619558
6.

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.

Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, Malice MP, Reiss TF; Montelukast Spring Rhinitis Study Group.

Clin Exp Allergy. 2002 Jul;32(7):1020-8. Erratum in: Clin Exp Allergy. 2009 Oct;39(10):1622.

PMID:
12100048
7.

Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Nayak A, Langdon RB.

Drugs. 2007;67(6):887-901. Review.

PMID:
17428106
8.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
9.

The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency.

Roa J, Morikawa H, Crawford L, Baatjes A, Duong M, Denburg JA.

Immunology. 2007 Nov;122(3):438-44. Epub 2007 Jul 11.

10.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
11.

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.

van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF; Montelukast Spring Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):214-22.

PMID:
12602669
12.

Effects of montelukast on quality of life in patients with persistent allergic rhinitis.

Cingi C, Ozlugedik S.

Otolaryngol Head Neck Surg. 2010 May;142(5):654-8. doi: 10.1016/j.otohns.2010.01.016.

PMID:
20416451
13.

Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?

Keskin O, Alyamac E, Tuncer A, Dogan C, Adalioglu G, Sekerel BE.

Pediatr Allergy Immunol. 2006 Jun;17(4):259-68.

PMID:
16771779
14.

Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.

Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V.

Eur Ann Allergy Clin Immunol. 2004 Feb;36(2):67-70, 72.

PMID:
15061398
15.
16.

Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.

Minoguchi K, Kohno Y, Minoguchi H, Kihara N, Sano Y, Yasuhara H, Adachi M.

Chest. 2002 Mar;121(3):732-8.

PMID:
11888953
17.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
18.

A review of montelukast in the treatment of asthma and allergic rhinitis.

Nayak A.

Expert Opin Pharmacother. 2004 Mar;5(3):679-86. Review.

PMID:
15013935
19.

Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.

van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF; Montelukast Fall Rhinitis Study Group.

Allergy. 2003 Dec;58(12):1268-76. Erratum in: Allergy. 2004 Mar;59(3):357. Allergy. 2009 Nov;64(11):1697.

PMID:
14616102
20.

Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.

Lehtimäki L, Petäys T, Haahtela T.

Int Arch Allergy Immunol. 2009;149(2):150-3. doi: 10.1159/000189198. Epub 2009 Jan 6.

PMID:
19127072
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk